| Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways MC Boelens*, TJ Wu*, BY Nabet* (co-first), B Xu, Y Qiu, T Yoon, ... Cell 159 (3), 499-513, 2014 | 808 | 2014 |
| Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities CM Gay, CA Stewart, EM Park, L Diao, SM Groves, S Heeke, BY Nabet, ... Cancer cell 39 (3), 346-360. e7, 2021 | 513 | 2021 |
| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 454 | 2020 |
| Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer BY Nabet, Y Qiu, JE Shabason, TJ Wu, T Yoon, BC Kim, JL Benci, ... Cell 170 (2), 352-366. e13, 2017 | 414 | 2017 |
| Exosomes in the tumor microenvironment as mediators of cancer therapy resistance I Li, BY Nabet Molecular cancer 18 (1), 32, 2019 | 331 | 2019 |
| Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition BY Nabet*, MS Esfahani* (co-first), EJ Moding, EG Hamilton, JJ Chabon, ... Cell 183 (2), 363-376. e13, 2020 | 251 | 2020 |
| Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner O Gilad, BY Nabet, RL Ragland, DW Schoppy, KD Smith, AC Durham, ... Cancer research 70 (23), 9693-9702, 2010 | 251 | 2010 |
| Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer EJ Moding, Y Liu, BY Nabet, JJ Chabon, AA Chaudhuri, AB Hui, ... Nature Cancer 1 (2), 176-183, 2020 | 238 | 2020 |
| Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification AM Leader, JA Grout, BB Maier, BY Nabet, MD Park, A Tabachnikova, ... Cancer cell 39 (12), 1594-1609. e12, 2021 | 176 | 2021 |
| Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer NS Patil*, BY Nabet* (co-first/co-corresponding), S Müller, H Koeppen, ... Cancer Cell, 2022 | 170 | 2022 |
| Detection and surveillance of bladder cancer using urine tumor DNA JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ... Cancer discovery 9 (4), 500-509, 2019 | 159 | 2019 |
| Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease in Solid Tumors EJ Moding, BY Nabet, AA Alizadeh, M Diehn Cancer discovery 11 (12), 2968-2986, 2021 | 136 | 2021 |
| The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma CB Steen, BA Luca, MS Esfahani, A Azizi, BJ Sworder, BY Nabet, ... Cancer cell 39 (10), 1422-1437. e10, 2021 | 125 | 2021 |
| LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity AT Krishnamurty, JA Shyer, M Thai, V Gandham, MB Buechler, YA Yang, ... Nature 611 (7934), 148-154, 2022 | 117 | 2022 |
| KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ... Cancer discovery 10 (12), 1826-1841, 2020 | 100 | 2020 |
| Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L) 1 blockade in NSCLC MD Hellmann*, BY Nabet* (co-first), H Rizvi, AA Chaudhuri, DK Wells, ... Clinical Cancer Research 26 (12), 2849-2858, 2020 | 94 | 2020 |
| Lesion-level response dynamics to programmed cell death protein (PD-1) blockade JC Osorio, KC Arbour, DT Le, JN Durham, AJ Plodkowski, DF Halpenny, ... Journal of Clinical Oncology 37 (36), 3546-3555, 2019 | 88 | 2019 |
| Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery SH Chiou, D Tseng, A Reuben, V Mallajosyula, IS Molina, S Conley, ... Immunity 54 (3), 586-602. e8, 2021 | 87 | 2021 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 76 | 2022 |
| Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy AJ Wisdom, YM Mowery, CS Hong, JE Himes, BY Nabet, X Qin, D Zhang, ... Nature communications 11 (1), 6410, 2020 | 69 | 2020 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of MedicineVerified email at stanford.edu
